{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:02:40Z","timestamp":1789203760007,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"publisher","award":["EDAHT-101022"],"award-info":[{"award-number":["EDAHT-101022"]}],"id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.canlet.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T15:25:26Z","timestamp":1439306726000},"page":"144-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells"],"prefix":"10.1016","volume":"368","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3269-521X","authenticated-orcid":false,"given":"Chih-Cheng","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-I.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shian","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Chieh","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chu","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Huang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-9384","authenticated-orcid":false,"given":"Ying-Hsien","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2015.08.004_bib0010","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI36551","article-title":"Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance","volume":"120","author":"Cherfils-Vicini","year":"2010","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2015.08.004_bib0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605558","article-title":"High expression of Toll-like receptor 4\/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer","volume":"102","author":"Wang","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2015.08.004_bib0020","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/pros.20984","article-title":"Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer","volume":"69","author":"Gatti","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2015.08.004_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1756-9966-29-92","article-title":"Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion","volume":"29","author":"Yang","year":"2010","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2015.08.004_bib0030","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/mc.20325","article-title":"Increased toll-like receptor 9 expression in cervical neoplasia","volume":"46","author":"Lee","year":"2007","journal-title":"Mol. Carcinog"},{"key":"10.1016\/j.canlet.2015.08.004_bib0035","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1158\/1535-7163.MCT-08-0582","article-title":"Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors","volume":"7","author":"Goto","year":"2008","journal-title":"Mol. Cancer Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.canlet.2015.08.004_bib0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12307-009-0022-y","article-title":"Cancer cells expressing toll-like receptors and the tumor microenvironment","volume":"2","author":"Sato","year":"2009","journal-title":"Cancer Microenviron"},{"key":"10.1016\/j.canlet.2015.08.004_bib0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2015.08.004_bib0050","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s12272-012-0802-7","article-title":"Roles of toll-like receptors in cancer: a double-edged sword for defense and offense","volume":"35","author":"Basith","year":"2012","journal-title":"Arch. Pharm. Res"},{"key":"10.1016\/j.canlet.2015.08.004_bib0055","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.molimm.2007.01.022","article-title":"TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance","volume":"44","author":"He","year":"2007","journal-title":"Mol. Immunol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.onc.1210904","article-title":"TLR signaling by tumor and immune cells: a double-edged sword","volume":"27","author":"Huang","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.08.004_bib0065","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/1541-7786.MCR-07-2005","article-title":"Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion","volume":"6","author":"Ilvesaro","year":"2008","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.canlet.2015.08.004_bib0070","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/onc.2009.289","article-title":"TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer","volume":"28","author":"Szajnik","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2015.08.004_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-319-09614-8_8","article-title":"TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis","volume":"815","author":"Machida","year":"2015","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0080","first-page":"141","article-title":"Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection","volume":"13","author":"Shehata","year":"2006","journal-title":"Egypt. J. Immunol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0085","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-3083.2005.01670.x","article-title":"Tissue localization of Toll-like receptors in biopsy specimens of liver from children infected with hepatitis C virus","volume":"62","author":"Mozer-Lisewska","year":"2005","journal-title":"Scand. J. Immunol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0090","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/JVI.80.2.866-874.2006","article-title":"Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6","volume":"80","author":"Machida","year":"2006","journal-title":"J. Virol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/hepr.12180","article-title":"Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: relationship with clinicopathological characteristics and prognosis","volume":"44","author":"Eiro","year":"2014","journal-title":"Hepatol. Res"},{"key":"10.1016\/j.canlet.2015.08.004_bib0100","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2015.08.004_bib0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bpg.2003.10.005","article-title":"Gut microflora in the pathogenesis of the complications of cirrhosis","volume":"18","author":"Garcia-Tsao","year":"2004","journal-title":"Best Pract. Res. Clin. Gastroenterol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2015.08.004_bib0115","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s10620-013-2745-3","article-title":"Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma","volume":"58","author":"Wang","year":"2013","journal-title":"Dig. Dis. Sci"},{"key":"10.1016\/j.canlet.2015.08.004_bib0120","doi-asserted-by":"crossref","first-page":"10429","DOI":"10.1007\/s13277-014-2347-5","article-title":"LPS promotes epithelial-mesenchymal transition and activation of TLR4\/JNK signaling","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1741-7015-10-98","article-title":"Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide","volume":"10","author":"Jing","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.canlet.2015.08.004_bib0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2014.12.019","article-title":"Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma","volume":"358","author":"Liu","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2015.08.004_bib0135","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","article-title":"TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer","volume":"66","author":"Kelly","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2015.08.004_bib0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc1910","article-title":"The role of nitric oxide in tumour progression","volume":"6","author":"Fukumura","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2015.08.004_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2014.07.014","article-title":"Nitric oxide in cancer metastasis","volume":"353","author":"Cheng","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2015.08.004_bib0150","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.18632\/oncotarget.3234","article-title":"Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine","volume":"6","author":"Kishikawa","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2015.08.004_bib0155","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/path.4545","article-title":"High nitric oxide production, secondary to inducible-nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells","volume":"236","author":"Puglisi","year":"2015","journal-title":"J. Pathol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0160","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/1097-0142(1967)20:3<396::AID-CNCR2820200308>3.0.CO;2-O","article-title":"Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases","volume":"20","author":"Ishak","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2015.08.004_bib0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/pbc.24211","article-title":"Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro","volume":"60","author":"Hsiao","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2015.08.004_bib0170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.taap.2011.06.008","article-title":"A DC-81-indole conjugate agent suppresses melanoma A375 cell migration partially via interrupting VEGF production and stromal cell-derived factor-1alpha-mediated signaling","volume":"255","author":"Hsieh","year":"2011","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0175","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/tx025652a","article-title":"Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro","volume":"16","author":"Kao","year":"2003","journal-title":"Chem. Res. Toxicol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1046\/j.1472-8206.2003.00182.x","article-title":"Activation of DNA biosynthesis in human hepatoblastoma HEPG2 cells by the nitric oxide donor, sodium nitroprusside","volume":"17","author":"Sokolowska","year":"2003","journal-title":"Fundam. Clin. Pharmacol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0185","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MAJ.0b013e3181cef1b7","article-title":"Expression and functional research of TLR4 in human colon carcinoma","volume":"339","author":"Tang","year":"2010","journal-title":"Am. J. Med. Sci"},{"key":"10.1016\/j.canlet.2015.08.004_bib0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2005.04.006","article-title":"Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4","volume":"235","author":"Molteni","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2015.08.004_bib0195","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1089\/10799900050163299","article-title":"Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes","volume":"20","author":"Matsumura","year":"2000","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1016\/j.canlet.2015.08.004_bib0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1432-1327.1999.00141.x","article-title":"Lipopolysaccharide stimulates HepG2 human hepatoma cells in the presence of lipopolysaccharide-binding protein via CD14","volume":"260","author":"Nanbo","year":"1999","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.canlet.2015.08.004_bib0205","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hep.21328","article-title":"Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas","volume":"44","author":"Luo","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2015.08.004_bib0210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.smim.2014.01.008","article-title":"The two faces of IL-6 in the tumor microenvironment","volume":"26","author":"Fisher","year":"2014","journal-title":"Semin. Immunol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0215","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.23845","article-title":"Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents","volume":"52","author":"Yu","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2015.08.004_bib0220","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1245\/s10434-009-0325-8","article-title":"Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis","volume":"16","author":"Earl","year":"2009","journal-title":"Ann. Surg. Oncol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0225","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/gast.2002.34234","article-title":"Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha\/kallikrein-mediated activation of latent TGF-beta","volume":"123","author":"Akita","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2015.08.004_bib0230","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1172\/JCI65859","article-title":"Reciprocal regulation by TLR4 and TGF-beta in tumor-initiating stem-like cells","volume":"123","author":"Chen","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2015.08.004_bib0235","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2009.07.013","article-title":"Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients","volume":"52","author":"Chew","year":"2010","journal-title":"J. Hepatol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0240","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnci\/95.4.316","article-title":"Involvement of Toll-like receptor 4 signaling in interferon-gamma production and antitumor effect by streptococcal agent OK-432","volume":"95","author":"Okamoto","year":"2003","journal-title":"J. Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2015.08.004_bib0245","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/gut.2009.190835","article-title":"Toll-like receptors 2\/4 agonists: a potential strategy for preventing invasion and metastasis of hepatocellular carcinoma","volume":"59","author":"Yu","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2015.08.004_bib0250","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.mehy.2013.06.034","article-title":"TAK-242 can be the potential agents for preventing invasion and metastasis of hepatocellular carcinoma","volume":"81","author":"Yu","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.canlet.2015.08.004_bib0255","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2014.11.090","article-title":"CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-kappaB and MAPK pathway","volume":"456","author":"Wang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.canlet.2015.08.004_bib0260","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s10620-005-2775-6","article-title":"Nitric oxide-dependent osteopontin expression induces metastatic behavior in HepG2 cells","volume":"50","author":"Guo","year":"2005","journal-title":"Dig. Dis. Sci"},{"key":"10.1016\/j.canlet.2015.08.004_bib0265","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ijc.10632","article-title":"Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion","volume":"101","author":"Harmey","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2015.08.004_bib0270","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s10753-013-9638-7","article-title":"TLR4 mediates MAPK-STAT3 axis activation in bladder epithelial cells","volume":"36","author":"Ying","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.canlet.2015.08.004_bib0275","first-page":"2473","article-title":"Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells","volume":"29","author":"Doan","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canlet.2015.08.004_bib0280","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.molimm.2009.06.016","article-title":"Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity","volume":"46","author":"Hua","year":"2009","journal-title":"Mol. Immunol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0285","doi-asserted-by":"crossref","first-page":"12345","DOI":"10.1007\/s13277-014-2547-z","article-title":"A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population","volume":"35","author":"Jiang","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canlet.2015.08.004_bib0290","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic death of colon cancer cells treated with oxaliplatin","volume":"29","author":"Tesniere","year":"2010","journal-title":"Oncogene"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515005339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383515005339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T12:17:28Z","timestamp":1542370648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383515005339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0304383515005339"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2015.08.004","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}